Department of Surgery, Sapienza University of Rome, Rome, Italy.
Department of Surgery, Department of Medicine of Precision and Regenerative and Jonic Area (DiMePRe-J,), University Hospital of Bari, Bari, Italy.
Updates Surg. 2024 Sep;76(5):2087-2090. doi: 10.1007/s13304-024-01798-3. Epub 2024 Mar 13.
Injection sclerotherapy is an effective and safe treatment in selected cases. It might be used as the first treatment for I-III degree hemorrhoidal disease (HD), but also as a bridge therapy for more severe cases not amenable to invasive treatments. However, concerning the long-term recurrence rate, open excisional hemorrhoidectomy remains the gold standard in cases of III- and IV-degree HD. In this context, it is recommended to perform the excision of no more than three piles and to preserve the muco-cutaneous bridges to avoid post-operative anal stenosis. The aim of this study is to evaluate surgical outcomes and efficacy of the combined treatment of open excisional hemorrhoidectomy and the use of ST on the remnant muco-cutaneous bridges/residual piles. This was a single-center retrospective study and a total of 18 patients with IV-degree HD, aged between 18 and 75 years with symptomatic HD according to the Goligher classification, were enrolled between January 2023 and June 2023 and their follow-up continued until October 2023 after reaching 3 months of follow-up. The Hemorrhoidal Disease Symptom Score (HDSS), the Short Health Scale for HD (SHS-HD) score and the Vaizey Incontinence Score were used to assess symptoms and their impact on quality of life and continence. A total of 77.8% (14/18) of the patients were symptom-free (hemorrhoidal disease symptom score (HDSS) score = 0) after 3 months. Moreover, a statistically significant decrease in the median HDSS and short health scale for HD (SHS-HD) score was registered from 16 preoperatively (T0) to 2 at 3-month follow-up (T3). Neither post-operative bleeding nor any type of complications occurred. The use of sclerotherapy in combination with the traditional open excisional hemorrhoidectomy has shown promising results. Further structured studies are needed and greater dissemination and education of the general surgeon on the subject is necessary.
注射硬化疗法在选定病例中是一种有效且安全的治疗方法。它可作为 I-III 度痔病(HD)的首选治疗方法,但也可作为对更严重病例(不适合侵入性治疗)的桥接治疗。然而,关于长期复发率,开放式切除痔切除术仍然是 III-IV 度 HD 的金标准。在这种情况下,建议切除不超过三个痔核,并保留黏膜皮桥以避免术后肛门狭窄。本研究旨在评估开放式切除痔切除术联合 ST 治疗残余黏膜皮桥/残留痔核的手术效果和疗效。这是一项单中心回顾性研究,共纳入 18 例年龄在 18-75 岁之间的 IV 度 HD 患者,根据 Goligher 分类,他们有症状性 HD,并且在 2023 年 1 月至 6 月期间进行了随访,直到达到 3 个月的随访后,在 2023 年 10 月结束。采用痔病症状评分(HDSS)、痔病简明健康量表(SHS-HD)评分和 Vaizey 失禁评分评估症状及其对生活质量和控便能力的影响。18 例患者中,77.8%(14/18)在 3 个月后无任何症状(痔病症状评分(HDSS)评分=0)。此外,术前 16 例(T0)和 3 个月随访时 2 例(T3)的中位数 HDSS 和痔病简明健康量表(SHS-HD)评分均显著降低。术后无出血或任何类型的并发症发生。硬化疗法联合传统开放式切除痔切除术的应用显示出良好的效果。需要进一步开展结构化研究,并加强普通外科医生对该主题的普及和教育。